The Future of Acute Myeloid Leukemia Care: Market Insights Through 2034
Acute myeloid leukemia (AML) is a rapidly progressing blood cancer characterized by the abnormal growth of immature myeloid cells in the bone marrow and blood. Increasing awareness of the disease, advances in diagnostic technologies, and improvements in cancer care are transforming the approach to AML diagnosis and treatment. Healthcare providers are increasingly adopting molecular testing and...
0 Yorumlar 0 hisse senetleri 3 Views 0 önizleme
G-0QEH8T2MGD